TITLE

Potential Treatment of Cardiac Hypertrophy and Heart Failure by Inhibiting the Sarcolemmal Binding of Phospholipase C�1b

AUTHOR(S)
Woodcock, E. A.; Grubb, D. R.; Iliades, P.
PUB. DATE
August 2010
SOURCE
Current Drug Targets;Aug2010, Vol. 11 Issue 8, p1032
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
56952389

 

Related Articles

  • Omapatrilat induces profound renal vasodilation but does not affect coronary hemodynamics. Varagic, Jasmina; Susic, Dinko; Slama, Michel; Frohlich, Edward D. // Journal of Cardiovascular Pharmacology & Therapeutics;Jun2003, Vol. 8 Issue 2, p167 

    Background: Omapatrilat has potent enzymatic inhibitory effects on the angiotensin-converting enzyme and neutral endopeptidase. The prolonged effects of this inhibition on systemic and regional hemodynamics, cardiovascular mass, and hydroxyproline concentration in spontaneously...

  • A novel porcine model of early left ventricular dysfunction for translational research. Malik, Nadim; Farrell, Kelly A.; Withers, Sarah B.; Wright, Elizabeth J.; Holt, Cathy M. // Research Reports in Clinical Cardiology;2013, Vol. 4, p1 

    Background: The early stages of left ventricular (LV) dysfunction account for a much larger proportion of the population with heart disease than that with clinical heart failure. However, LV dysfunction is more difficult to diagnose than established heart failure, and because of this it is not...

  • A Novel Vasoactive Proline-Rich Oligopeptide from the Skin Secretion of the Frog Brachycephalus ephippium. Arcanjo, Daniel Dias Rufino; Vasconcelos, Andreanne Gomes; Comerma-Steffensen, Simón Gabriel; Jesus, Joilson Ramos; Silva, Luciano Paulino; JúniorPires, Osmindo Rodrigues; Costa-Neto, Claudio Miguel; Oliveira, Eduardo Brandt; Migliolo, Ludovico; Franco, Octávio Luiz; Restini, Carolina Baraldi Araújo; Paulo, Michele; Bendhack, Lusiane Maria; Bemquerer, Marcelo Porto; Oliveira, Aldeidia Pereira; Simonsen, Ulf; Leite, José Roberto de Souza de Almeida // PLoS ONE;12/14/2015, Vol. 10 Issue 12, p1 

    Proline-rich oligopeptides (PROs) are a large family which comprises the bradykinin-potentiating peptides (BPPs). They inhibit the activity of the angiotensin I-converting enzyme (ACE) and have a typical pyroglutamyl (Pyr)/proline-rich structure at the N- and C-terminus, respectively....

  • ‘ACE inhibitors are better than AT1 receptor blockers (ARBs)’ – controversies in heart failure. White, Hazel L.; Hall, Alistair S. // European Journal of Heart Failure;Sep2000, Vol. 2 Issue 3, p237 

    The article discusses the potential impact of Angiotensin-converting enzyme (ACE) inhibitors as a treatment for cardiac heart failure. It states that ACE inhibitors are more effective than the angiotensin II receptor blockers (ARBs). It mentions that Angiotensin II is a potent trophic stimulus...

  • Neurohormonal antagonism in heart failure; beneficial effects of vasopressin V1a and V2 receptor blockade and ACE inhibition Naitoh, Mareo; Risvanis, John; Balding, Leanne C.; Johnston, Colin I.; Burrell, Louise M. // Cardiovascular Research;Apr2002, Vol. 54 Issue 1, p51 

    Objective: To assess the long-term efficacy of vasopressin (AVP) V1a and V2 receptor blockade with conivaptan, alone and in combination with angiotensin converting enzyme (ACE) inhibition on blood pressure, metabolic and neurohormonal parameters, and cardiovascular structure in a rat...

  • BENEFITS OF ANGIOTENSIN CONVERTING ENZYME INHIBITION IN CARDIAC FAILURE.  // Heart;Nov2002 Supplement 4, Vol. 88, pIv32 

    Discusses an abstract of the study, titled 'Benefits of angiotensin converting enzyme inhibition in cardiac failure,' by S.L. Cunningham, K.H. Parker, J. Mayet, S.A.McG. Thom and A.D. Hughes.

  • The role of angiotensin II type 1a receptor on intestinal epithelial cells following small bowel resection in a mouse model. Koga, Hiroyuki; Hua Yang; Haxhija, Emir Q.; Teitelbaum, Daniel H.; Yang, Hua // Pediatric Surgery International;Dec2008, Vol. 24 Issue 12, p1279 

    Aim: We have previously shown that inhibition of angiotensin converting enzyme (ACE) significantly reduced intestinal epithelial cell (EC) apoptosis and improved morphometric intestinal adaptation in a mouse model of massive small-bowel resection (SBR). This study attempted to...

  • Intestinal intraepithelial lymphocyte derived angiotensin converting enzyme modulates epithelial cell apoptosis. Wildhaber, B. E.; Yang, H.; Haxhija, E. Q.; Spencer, A. U.; Teitelbaum, D. H. // Apoptosis;Nov2005, Vol. 10 Issue 6, p1305 

    Background & Aims: Intestinal adaptation in short bowel syndrome (SBS) consists of increased epithelial cell (EC) proliferation as well as apoptosis. Previous microarray analyses of intraepithelial lymphocytes (IEL) gene expression after SBS showed an increased expression of angiotensin...

  • FOXO3a mediates the androgen-dependent regulation of FLIP and contributes to TRAIL-induced apoptosis of LNCaP cells. Cornforth, A. N.; Davis, J. S.; Khanifar, E.; Nastiuk, K. L.; Krolewski, J. J. // Oncogene;7/24/2008, Vol. 27 Issue 32, p4422 

    Androgen-withdrawal-induced apoptosis (AWIA) is deregulated in androgen refractory prostate cancer. Androgens have been shown to positively regulate expression of the antiapoptotic FADD-like interleukin-1β-converting enzyme (FLICE)-like inhibitory protein (FLIP), and reduced FLIP expression...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics